| Arakis and GeneFormatics Collaborate on Performance Enhanced Medicines |
Abstract
pdf
|
|
Business Review Editor |
|
| Centocor and Neuronyx Enter Cardiovascular Stem Cell Collaboration |
Abstract
pdf
|
|
Business Review Editor |
|
| Stressgen Licenses Heat Shock Fusion Protein to Roche |
Abstract
pdf
|
|
Business Review Editor |
|
| Micrologix Licenses Anti-Infective to Fujisawa |
Abstract
pdf
|
|
Business Review Editor |
|
| VaxGen Amends Agreement with Genentech for AIDSVAX |
Abstract
pdf
|
|
Business Review Editor |
|
| Big Pharma Product Divestments– Buying the Cast-Offs |
Abstract
|
|
Business Review Editor |
|
| Shortening the Adoption Curve |
Abstract
|
|
Business Review Editor |
|
| Technology Focus: Pharmacogenomics |
Abstract
|
|
Business Review Editor |
|
| Pfizer to Acquire Pharmacia |
Abstract
pdf
|
|
Business Review Editor |
|
| Serono Launches Bid to Acquire Genset |
Abstract
pdf
|
|
Business Review Editor |
|
| Par Pharmaceutical to Market Three Rivers’ Ribavirin |
Abstract
pdf
|
|
Business Review Editor |
|
| Women First HealthCare Acquire Vaniqa from BMS |
Abstract
pdf
|
|
Business Review Editor |
|
| ICN to Market Pharmacia Products in Italy |
Abstract
pdf
|
|
Business Review Editor |
|